Cogent Biosciences Announces $230 Million Convertible Senior Notes Offering

Gibson Dunn has represented Cogent Biosciences, Inc., and Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT) has announced the pricing of its underwritten public…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here